abagovomab 31
abciximab 27
abituzumab 19
abrilumab 16
actoxumab 15
adalimumab 15
aducanumab 9
afasevikumab 16
alacizumab_pegol 13
alemtuzumab 24
alirocumab 17
amatuximab 36
andecaliximab 20
anifrolumab 20
anrukinzumab 16
aprutumab 13
aprutumab_ixadotin 13
arcitumomab 23
ascrinvacumab 6
atezolizumab 14
atinumab 12
avelumab 11
basiliximab 28
bavituximab 30
begelomab 22
benralizumab 22
bevacizumab_beta 17
bezlotoxumab 15
bimagrumab 11
bleselumab 13
blinatumomab 34
blosozumab 26
bococizumab 15
brazikumab 10
brentuximab_vedotin 21
briakinumab 15
brodalumab 6
brolucizumab 25
brontictuzumab 17
burosumab 15
cabiralizumab 17
camrelizumab 13
canakinumab 25
cantuzumab_ravtansin 42
carlumab 13
carotuximab 26
cergutuzumab_amunaleukin2 24
cergutuzumab_amunaleukin 24
certolizumab_pegol 21
cetiximab 37
citatuzumab_bogatox 24
cixutumumab 23
clivatuzumab_tetraxetan 18
codrituzumab 26
conatumumab 6
concizumab 28
crenezumab 16
crizanlizumab 19
crotedumab 17
dacetuzumab 18
daclizumab 14
dalotuzumab 32
dapirolizumab_pegol 23
daratumumab 13
dectrekumab 9
demcizumab 18
denosumab 11
depatuxizumab 17
depatuxizumab_mafodotin 17
dezamizumab 16
dinutuximab 33
diridavumab 13
domagrozumab 14
drozitumab 16
duligotuzumab 18
durvalumab 10
dusigitumab 8
efalizumab 27
efungumab 28
eldelumab 11
elezanumab 13
elgemtumab 9
elotuzumab 15
emactuzumab 16
emapalumab 22
emibetuzumab 13
enavatuzumab 23
enfortumab_vedotin 9
enoblituzumab 15
enokizumab 19
enoticumab 14
ensituximab 31
eptinezumab 17
erenumab 14
etaracizumab 17
etrolizumab 19
evinacumab 20
evolocumab 11
farletuzumab 12
fasinumab 19
fezakinumab 11
fibatuzumab 7
ficlatuzumab 14
firivumab 28
flanvotumab 14
fletikumab 19
foralumab 11
foravirumab 11
fremanezumab 24
fresolimumab 16
fulranumab 19
futuximab 17
galcanezumab 15
ganitumab 23
gantenerumab 10
gemetuzumab 23
gemtuzumab2 21
gemtuzumab 24
gevokizumab 19
girentuximab 27
glembatumumab 13
glembatumumab_vedotin 13
guselkumab 19
ibalizumab 23
ibritumomab 29
icrucumab 6
idarucizumab 24
ifabotuzumab 7
imalumab 14
imgatuzumab 15
inclacumab 11
indatuximab_ravtansin 29
indusatumab 13
inebilizumab 27
intetumumab 8
iodine_girentuximab 25
ipilimumab 3
iratumumab 9
isatuximab 33
itolizumab 22
ixekizumab 29
labetuzumab_govitecan 21
lambrolizumab 24
lampalizumab 22
lanadelumab 15
landogrozumab 16
laprituximab 24
lebrikizumab 35
lendalizumab 20
lenzilumab 12
lifastuzumab_vedotin 21
ligelizumab 21
lilotomab 36
lirilumab 14
lodelcizumab 10
lokivetmab 23
lorvotuzumab_mertansin 18
lucatumumab 25
lumretuzumab 12
lupartumab 8
lutikizumab 19
margetuximab 33
milatuzumab 31
mirvetuximab 31
mirvetuximab_soravtansin 31
modotuximab 31
mogamulizumab 28
monalizumab 15
motavizumab 26
moxetumomab_pasudotox 26
namilumab 13
naratuximab 23
naratuximab_emtansin 23
narnatumab 13
navicixizumab2 24
navicixizumab 19
navivumab 32
necitumumab 8
nemolizumab 20
nesvacumab 13
nivolumab 12
obiltoxaximab 21
obinutuzumab 33
ocaratuzumab 25
ofatumumab 13
olaratumab 12
olokizumab 22
omalizumab 18
onartuzumab 19
ontuxizumab 22
opicinumab 13
orticumab 9
otelixizumab 33
oxelumab 10
ozanezumab 25
pamrevlumab 6
panobacumab 19
parsatuzumab 20
pasotuxizumab 20
pateclizumab 13
patritumab 16
pembrolizumab 24
perakizumab 17
pidilizumab 18
pinatuzumab_vedotin 16
plozalizumab 29
pogalizumab 21
polatuzumab_vedotin 18
ponezumab 31
prezalumab 12
pritoxaximab 32
quilizumab 19
racotumomab 20
radretumab 13
ralpancizumab 19
ramucirumab 13
ranevetmab 17
ranibizumab 19
refanezumab 22
remtolumab 14
rilotumumab 13
rinucumab 17
risankizumab 34
rituximab 19
rivabazumab 13
robatumumab 19
roledumab 23
romosozumab 19
rontalizumab 19
rosmantuzumab 18
rozanolixizumab 16
sacituzumab 21
sacituzumab_govitecan 21
samalizumab 21
sapelizumab 21
sarilumab 12
secukinumab 13
seribantumab 14
setoxaximab 41
sifalimumab 8
siltuximab 25
simtuzumab 24
sirukumab 11
solanezumab 20
solitomab 24
stamulumab 17
suptavumab 15
suvizumab 17
tabalumab 9
tadocizumab 11
tamtuvetmab 32
tanezumab 20
tarextumab 8
tavolixizumab 15
telisotuzumab 25
teplizumab 17
tesidolumab 15
tezepelumab 20
tigatuzumab 16
tildrakizumab 18
timolumab 13
tisotumab 10
tosatoxumab 31
tositumomab 29
tralokinumab 23
trastuzumab 20
tregalizumab 28
trevogrumab 12
ublituximab 29
urelumab 15
ustekinumab 23
utomilumab 26
vadastuximab 21
vadastuximab_talirin 21
vandortuzumab_vedotin 11
vantictumab 17
vanucizumab2 17
vanucizumab 23
varlilumab 11
vatelizumab 17
vedolizumab 25
veltuzumab 13
vesencumab 12
vorsetuzumab 15
vorsetuzumab_mafodotin 15
vunakizumab 29
xentuzumab 15
zatuximab 31
